The justification is being used for a similar investigation on pharmaceuticals and pharmaceutical ingredients, which was also disclosed on Monday.
The U.S. is heavily dependent on semiconductor technology imported from markets like Taiwan, South Korea, and the Netherlands.
However, for years, Washington has been implementing policies aimed at onshoring more of the semiconductor supply chain, including through industrial policies such as the $280 billion CHIPS and Science Act.